Mycenax Biotech Inc. (TPEX:4726)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
37.50
+0.20 (0.54%)
Apr 2, 2025, 1:30 PM CST

Mycenax Biotech Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
683.92652.62732.28774.27665.34
Upgrade
Revenue Growth (YoY)
4.80%-10.88%-5.42%16.37%70.23%
Upgrade
Cost of Revenue
925.281,028845.95636.66478.81
Upgrade
Gross Profit
-241.36-375.19-113.67137.61186.53
Upgrade
Selling, General & Admin
141.94152.23156.16133.9693.77
Upgrade
Research & Development
78.1975.8114496.1346.5
Upgrade
Operating Expenses
220.18226.91331.32222.94151.13
Upgrade
Operating Income
-461.54-602.1-445-85.3335.4
Upgrade
Interest Expense
-26.16-23.46-15.42-1.17-0.87
Upgrade
Interest & Investment Income
8.5317.663.80.311.48
Upgrade
Earnings From Equity Investments
-12.94-8.7-0.76--
Upgrade
Currency Exchange Gain (Loss)
14.583.3513.29-1.35-9.22
Upgrade
Other Non Operating Income (Expenses)
-4.960.750.21-0.110.9
Upgrade
EBT Excluding Unusual Items
-482.5-612.5-443.87-87.6527.7
Upgrade
Gain (Loss) on Sale of Assets
---20.110.130.27
Upgrade
Other Unusual Items
1.07-71.481.13--
Upgrade
Pretax Income
-469.59-683.98-462.84-87.5227.97
Upgrade
Income Tax Expense
-2.46-1.13-9.212.34-2.98
Upgrade
Net Income
-467.13-682.85-453.63-89.8630.95
Upgrade
Net Income to Common
-467.13-682.85-453.63-89.8630.95
Upgrade
Shares Outstanding (Basic)
206206165148128
Upgrade
Shares Outstanding (Diluted)
206206165148129
Upgrade
Shares Change (YoY)
0.23%24.31%11.35%15.36%2.37%
Upgrade
EPS (Basic)
-2.27-3.32-2.74-0.610.24
Upgrade
EPS (Diluted)
-2.27-3.32-2.74-0.610.24
Upgrade
Free Cash Flow
-522.11-426.81-777.12-1,244-86.04
Upgrade
Free Cash Flow Per Share
-2.54-2.08-4.70-8.38-0.67
Upgrade
Gross Margin
-35.29%-57.49%-15.52%17.77%28.04%
Upgrade
Operating Margin
-67.48%-92.26%-60.77%-11.02%5.32%
Upgrade
Profit Margin
-68.30%-104.63%-61.95%-11.61%4.65%
Upgrade
Free Cash Flow Margin
-76.34%-65.40%-106.12%-160.71%-12.93%
Upgrade
EBITDA
-206.91-338.27-219.744.33150.83
Upgrade
EBITDA Margin
-30.25%-51.83%-30.00%5.73%22.67%
Upgrade
D&A For EBITDA
254.63263.83225.3129.66115.43
Upgrade
EBIT
-461.54-602.1-445-85.3335.4
Upgrade
EBIT Margin
-67.48%-92.26%-60.77%-11.02%5.32%
Upgrade
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.